Purchase Order 75F40122P00288
- Not listed
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Vitrocell Systems GMBH, a foreign-owned limited liability company that manufactures specialized equipment for in vitro characterization of airborne substances. The $63,600.00 contract is for on-site annual preventive maintenance of a Vitrocell 24/48 exposure system used by the FDA. This contract was awarded under a solicitation with no set-aside, as Vitrocell Systems GMBH provides highly specialized...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Vitrocell Systems GMBH, a German-based manufacturer of specialized laboratory equipment. The contract provides for preventative maintenance services on a Vitrocell 24/48 exposure module system used by the FDA's National Center for Toxicological Research to conduct research on tobacco products and electronic nicotine delivery systems. The contract has a total ceiling value of $158,220.00 and...
- This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Vitrocell Systems GMBH, a foreign-owned limited liability company based in Germany. The $611,231.64 firm-fixed-price purchase order is for a "HIGH TEMP SPIKING SYSTEM WITH POST-WARRANTY PREVENTATIVE MAINTENANCE OPTIONS" to support the FDA's research, testing, and evaluation programs. Vitrocell Systems GMBH is a manufacturer of...
- This is a federal contract award to Vitrocell Systems GMBH, a foreign-owned for-profit company based in Germany. The contract, awarded by the U.S. Food and Drug Administration (FDA), is for the delivery of "AEROSOL NANOPARTICLE EXPOSURE MODULES WITH POST-WARRANTY PREVENTATIVE MAINTENANCE AGREEMENT" at a ceiling value of $152,333.79. The contract is a firm fixed-price delivery order with an ultimate completion date of October 31, 2020. The contract does not have a set-aside designation....
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Vitrocell Systems GMBH, a foreign-owned manufacturer of specialized laboratory equipment, for a service contract on a Vitrocell VC-10 S-type smoking robot with two 12/12 exposure modules. The contract has a ceiling value of $158,800.00 and a period of performance ending on May 16, 2025. No set-aside was used for this award. Vitrocell Systems GMBH has previously provided the FDA with smoking...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed price purchase order to Vitrocell Systems GMBH, a foreign-owned limited liability company and manufacturer of goods, for a VITROCELL/GASMET CX4000 FTIR Gas Analyzer System. The award, valued at $138,788.80, was made on a sole-source basis and did not include any set-aside designations. Vitrocell Systems GMBH has provided the FDA with specialized laboratory equipment and services, such as...
- The U.S. Food and Drug Administration (FDA) awarded a $103,150.00 firm fixed-price purchase order contract to Vitrocell Systems GMBH, a German-based manufacturer of advanced laboratory equipment. The contract is for a Preventative Maintenance service agreement on a Vitrocell VC-10 S-type smoking robot located at the FDA's National Center for Toxicological Research (NCTR) in Jefferson, Arkansas. The contract has a base year plus four option years, for a total potential period of performance...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Vitrocell Systems GMBH, a foreign-owned, for-profit limited liability company that manufactures specialized laboratory equipment. The $632,191.88 contract is for the provision of an e-cigarette smoking machine, electronic nicotine delivery systems (ENDS), and a 24/48 exposure module for 6.5mm cell culture inserts, along with post-warranty preventative maintenance...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Vitrocell Systems GMBH, a German-based manufacturer of advanced laboratory equipment and systems for in vitro characterization of airborne substances. The $393,328.95 contract is for the provision of a cigarette smoking machine with preventative maintenance options to support the FDA's research, testing, and evaluation programs, particularly in the areas of tobacco product research, toxicology, and...
- The Environmental Protection Agency Office of Research and Development awarded a $153,409.18 firm-fixed-price purchase order to Vitrocell Systems GMBH, a manufacturer of specialized laboratory equipment, for the acquisition of a VITROCELL Cloud Alpha MOVE System or equivalent. This system will be used to support the agency's research, testing, and evaluation programs. The contract has an ultimate completion date of December 20, 2024 and does not have a set-aside designation. Vitrocell Systems...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Vitrocell Systems GMBH, a foreign-owned limited liability company that manufactures advanced equipment solutions for in vitro characterization of airborne substances. The contract is for on-site preventive maintenance services on a Vitrocell 24/48 exposure system used by the FDA. The contract has a ceiling value of $63,600.00 and a period of performance through July 25, 2025. No set-aside designation was used for this award. Vitrocell Systems GMBH has received previous prime contract awards and subcontract work from the FDA, Environmental Protection Agency, and Department of the Army to provide specialized laboratory equipment and services in support of research, testing, and evaluation programs. The parent company of Vitrocell Systems GMBH is Pieter Van Weenen & CO. GMBH.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 9/16/24 | |
| P00002 | Exercise an Option | $21.9k | 1/3/24 | |
| P00001 | Exercise an Option | $21.2k | 4/4/23 | |
| Not listed | Not listed | $20.5k | 7/25/22 |